Phreesia, Inc. Debt to Equity Ratio 2019-2024 | PHR
Current and historical debt to equity ratio values for Phreesia, Inc. (PHR) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Phreesia, Inc. debt/equity for the three months ending October 31, 2024 was 0.04.
| Phreesia, Inc. Debt/Equity Ratio Historical Data |
| Date |
Long Term Debt |
Shareholder's Equity |
Debt to Equity Ratio |
| 2024-10-31 |
$0.12B |
$0.26B |
0.48 |
| 2024-07-31 |
$0.11B |
$0.25B |
0.44 |
| 2024-04-30 |
$0.12B |
$0.25B |
0.47 |
| 2024-01-31 |
$0.12B |
$0.25B |
0.47 |
| 2023-10-31 |
$0.11B |
$0.27B |
0.42 |
| 2023-07-31 |
$0.09B |
$0.25B |
0.38 |
| 2023-04-30 |
$0.09B |
$0.26B |
0.34 |
| 2023-01-31 |
$0.08B |
$0.29B |
0.29 |
| 2022-10-31 |
$0.08B |
$0.32B |
0.24 |
| 2022-07-31 |
$0.08B |
$0.35B |
0.22 |
| 2022-04-30 |
$0.08B |
$0.38B |
0.20 |
| 2022-01-31 |
$0.08B |
$0.42B |
0.19 |
| 2021-10-31 |
$0.07B |
$0.46B |
0.16 |
| 2021-07-31 |
$0.07B |
$0.49B |
0.13 |
| 2021-04-30 |
$0.06B |
$0.50B |
0.12 |
| 2021-01-31 |
$0.06B |
$0.26B |
0.24 |
| 2020-10-31 |
$0.07B |
$0.27B |
0.25 |
| 2020-07-31 |
$0.06B |
$0.10B |
0.64 |
| 2020-04-30 |
$0.06B |
$0.10B |
0.61 |
| 2020-01-31 |
$0.06B |
$0.10B |
0.56 |
| 2019-10-31 |
$0.05B |
$0.10B |
0.52 |
| 2019-07-31 |
$0.06B |
$0.10B |
0.59 |
| 2019-04-30 |
$0.00B |
$0.00B |
0.00 |
| 2019-01-31 |
$0.00B |
|
0.00 |
| 2018-10-31 |
$0.00B |
$0.00B |
0.00 |
| 2018-07-31 |
$0.00B |
$0.00B |
0.00 |
| 2018-01-31 |
$0.00B |
$0.00B |
0.00 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MEDICAL INFO SYS |
$1.640B |
$0.356B |
|
Phreesia Inc. provides a patient intake management platform. The company's SaaS platform engages patients in their care and provides a modern, consistent experience, while enabling healthcare organizations to optimize their staffing, boost profitability and enhance clinical care. Phreesia Inc. is based in New York.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
| Veeva Systems Inc. (VEEV) |
US |
$36.657B |
54.02 |
| Hims & Hers Health, Inc. (HIMS) |
US |
$10.767B |
273.78 |
| Tempus AI, Inc. (TEM) |
US |
$10.720B |
0.00 |
| Inspire Medical Systems, Inc. (INSP) |
US |
$5.261B |
102.50 |
| iRhythm Technologies (IRTC) |
US |
$3.752B |
0.00 |
| Privia Health Group, Inc. (PRVA) |
US |
$2.942B |
245.20 |
| Enovis Corporation (ENOV) |
US |
$2.428B |
16.18 |
| Clover Health Investments, Corp. (CLOV) |
US |
$2.205B |
0.00 |
| Azenta, Inc. (AZTA) |
US |
$2.045B |
95.21 |
| Omnicell, Inc. (OMCL) |
US |
$1.840B |
40.12 |
| Schrodinger, Inc. (SDGR) |
US |
$1.650B |
0.00 |
| 10x Genomics (TXG) |
US |
$1.333B |
0.00 |
| Butterfly Network, Inc. (BFLY) |
US |
$0.916B |
0.00 |
| Talkspace, Inc. (TALK) |
US |
$0.508B |
300.50 |
| Fulgent Genetics, Inc. (FLGT) |
US |
$0.503B |
0.00 |
| Standard BioTools Inc. (LAB) |
US |
$0.484B |
0.00 |
| TruBridge, Inc. (TBRG) |
US |
$0.422B |
122.87 |
| Pulmonx Corporation (LUNG) |
US |
$0.354B |
0.00 |
| Nyxoah SA (NYXH) |
BE |
$0.352B |
0.00 |
| Health Catalyst, Inc. (HCAT) |
US |
$0.318B |
0.00 |
| SOPHiA GENETICS SA (SOPH) |
CH |
$0.266B |
0.00 |
| American Well Corporation (AMWL) |
US |
$0.183B |
0.00 |
| EUDA Health Holdings Limited (EUDA) |
SG |
$0.098B |
0.00 |
| MDxHealth SA (MDXH) |
BE |
$0.088B |
0.00 |
| P3 Health Partners Inc. (PIII) |
US |
$0.075B |
0.00 |
| 111, Inc. Sponsored ADR (YI) |
CN |
$0.072B |
0.00 |
| CareCloud, Inc. (CCLD) |
US |
$0.058B |
0.00 |
| HeartBeam, Inc. (BEAT) |
US |
$0.055B |
0.00 |
| Outset Medical, Inc. (OM) |
US |
$0.047B |
0.00 |
| Zepp Health Corporation Sponsored ADR (ZEPP) |
CN |
$0.045B |
0.00 |
| SHL Telemedicine Ltd. Unsponsored ADR (SHLT) |
IL |
$0.038B |
0.00 |
| Zhongchao Inc. (ZCMD) |
CN |
$0.035B |
0.00 |
| Movano Inc. (MOVE) |
US |
$0.033B |
0.00 |
| Bullfrog AI Holdings Inc. (BFRG) |
US |
$0.025B |
0.00 |
| MSP Recovery, Inc. (MSPR) |
US |
$0.016B |
0.00 |
| Streamline Health Solutions, Inc. (STRM) |
US |
$0.015B |
0.00 |
| Precipio, Inc. (PRPO) |
US |
$0.015B |
0.00 |
| ImmunoPrecise Antibodies Ltd. (IPA) |
CA |
$0.012B |
0.00 |
| Mobile-health Network Solutions (MNDR) |
SG |
$0.012B |
0.00 |
| Strata Skin Sciences, Inc. (SSKN) |
US |
$0.011B |
0.00 |
| Predictive Oncology Inc. (POAI) |
US |
$0.010B |
0.00 |
| Syra Health Corp. (SYRA) |
US |
$0.005B |
0.00 |
| Tivic Health Systems, Inc. (TIVC) |
US |
$0.004B |
0.00 |
| HeartSciences Inc. (HSCS) |
US |
$0.004B |
0.00 |
| Healthcare Triangle, Inc. (HCTI) |
US |
$0.003B |
0.00 |
| Future Health ESG Corp. (FHLT) |
US |
$0.000B |
0.00 |
